期刊文献+

参竹心康汤对慢性心力衰竭患者生活质量影响的临床研究 被引量:10

Effect of Shenzhu Xinkang decoction on quality of life in patients with chronic heart failure
原文传递
导出
摘要 目的:观察参竹心康汤对慢性心力衰竭(简称"心衰")患者心功能与生活质量的影响。方法:将91例慢性心衰患者随机分为治疗组46例与对照组45例。对照组以西医常规治疗,治疗组在对照组治疗基础上加服参竹心康汤。观察Lee氏心力衰竭计分、中医证候、生活质量、6min步行试验,采用高分辨率超声技术检测左室射血分数(LVEF)、二尖瓣舒张早期流速峰值(EPFV)、二尖瓣舒张晚期流速峰值(APFV)及二者之比(E/A)。结果:两组患者上述各项指标均有明显改善,且治疗组在心力衰竭及中医证候疗效、心功能指标、生活质量及6min步行距离等方面优于对照组,差异有统计学意义(P<0.05或P<0.01)。结论:参竹心康汤可提高慢性心衰患者的临床疗效,改善患者心功能和生活质量。 Objective :To observe the effects of Shenzhu Xinkang decoction on the cardiac function and quality of life (QOL) in patients with chronic heart failure (CHF). Methods :Ninety -one CHF patients were randomly di vided into treatment group (n = 46) and control group (n = 45 ). The control group received conventional West ern medicine treatment,while the treatment group received Shenzhu Xinkang decoction in addition to conventional Western medicine treatment. The therapeutic effects were assessed based on Left heart failure score, traditional Chi nese medicine (TCM) syndrome, QOL, and six - minute walk test. In addition, left ventricular ejection fraction, ear ly peak filling velocity ( EPFV), atrial peak filling velocity ( APFV), and the ratio of EPFV to APFV were measured by high -resolution ultrasound. Results:Both groups showed significant improvements in the above indices, and the treatment group was superior to the control group in terms of the outcomes of CHF and TCM syndrome, cardiac func- tion indices, QOL, and six - minute walk distance ( P 〈 0.05 or P 〈 0.01 ). Conclusion : Shenzhu Xinkang decoction can improve treatment outcome,cardiac function,and QOL in CHF patients.
出处 《湖南中医杂志》 2013年第9期9-12,共4页 Hunan Journal of Traditional Chinese Medicine
基金 湖南省中医药科研计划资助项目(编号:2009041)
关键词 慢性心衰 中医药疗法 参竹心康汤 chronic heart failure traditional Chinese medicine treatment Shenzhu Xinkang decoction
  • 相关文献

参考文献10

  • 1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3756
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2611
  • 3心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:568
  • 4Rector, T. S, Kubo, S. H, and Cohn, J. N. Validity of the minnesotaliving with heart failure questionnaire as a measure of therapeu-tic response to enalapril or placebo [ J] . Am Cardiol, 1993(71) :1106.
  • 5朱燕波,折笠秀樹,郑洁,霍艳明.心功能不全QOL量表中文译本信度效度的初步评价[J].中国行为医学科学,2004,13(3):337-339. 被引量:115
  • 6Guyatt GH,Sullivan MJ,Thompson PJ,et al. Thesix minute walk..A new measure of exercise capacity inpatients with chronic heartfailure[ J]. Can Med Assoc J,1985 ,132 :919 - 923.
  • 7Middel Bouma j,de Jongste M,et al. Psychometric properties of theMinnesota Living with Heart Failure Questionnaire ( MLHF -Q)[J]. Clin Rehabil,2001,15(5) :489 -500.
  • 8Alla F, Briancon S, Guillemin F,et al. Self - rating of quality oflife provides additional prognostic information in heart fail-ure. Insights into the EPICAL Study[ J]. Eur J Heart Fail,2002,4(3) :337 -343.
  • 9Faller H,Stork S,Schowalter M , et al. Is heal the related quali-ty oflife an independent predictor of survival in patients withchronic heart failure [ J] . J Psychosom Res,2007,63(5):533 -538.
  • 10Gonzalez - Alonso j, Calbet JA. Reductions in systemic andskeleta muscle blood flow and oxygen delivery limit maximal aero-bic capacity in humans [ J] . Circulation, 2003,107 ( 6 ):824 -830.(收稿日期:2013 -08 -20).

二级参考文献116

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:63
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 5Rector TS, Kubo SH, Cohn JN. Patientsself-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure,1987,3:198-209.
  • 6Cohn JN, Godldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med ,1998,339: 1810-1816.
  • 7Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire; reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J,1992,124:1017-1025.
  • 8Gorkin L, Norvell NK, Rosen RC, et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol,1993,71:1069-1073.
  • 9Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol,1993,71:1106-1107.
  • 10Hanyu N, Toy W, Burgess D, et al. Comparative responsiveness of short-form 12 and Minnesota Living with Heart Failure questionnaire in patients with heart failure. Journal of Cardiac Failure,2000,6(2):83-91.

共引文献7005

同被引文献119

引证文献10

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部